Company Filing History:
Years Active: 2018
Title: Bartholomaus Pieber: Innovator in Morphinan Alkaloid Reduction
Introduction
Bartholomaus Pieber is a notable inventor based in Graz, Austria. He has made significant contributions to the field of chemistry, particularly in the selective reduction of morphinan alkaloids. His innovative approach has implications for various applications in pharmaceuticals and chemical synthesis.
Latest Patents
Bartholomaus Pieber holds a patent for the selective reduction of morphinan alkaloids. The patent details a continuous flow system that selectively reduces thebaine or oripavine using hydrazine or a hydrazine-containing compound. This process occurs under elevated temperature and pressure conditions, resulting in the formation of 8,14-dihydrothebaine or 8,14-dihydrooripavine. This advancement showcases his expertise in chemical engineering and innovation.
Career Highlights
Pieber is currently associated with Noramco GmbH, where he continues to develop and refine his innovative techniques. His work has positioned him as a key figure in the field of alkaloid chemistry, contributing to advancements that may enhance drug development processes.
Collaborations
Throughout his career, Bartholomaus Pieber has collaborated with esteemed colleagues, including D Phillip Cox and C Oliver Kappe. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field.
Conclusion
Bartholomaus Pieber's contributions to the selective reduction of morphinan alkaloids highlight his innovative spirit and dedication to advancing chemical processes. His work not only reflects his expertise but also has the potential to impact the pharmaceutical industry significantly.